ALBUQUERQUE, N.M. — Editor’s note: An earlier version of this story incorrectly reported the amount of the cash deal for purchase of IntelliCyt.
The German pharmaceutical firm Sartorius AG has acquired one of New Mexico’s homegrown high-tech startups, IntelliCyt Corp., for $90 million.
The deal, one of the largest such acquisitions of a homegrown Albuquerque-based startup, is great news for IntelliCyt — which will continue to operate in New Mexico with its current 55-employee workforce — and for continuing to build the local startup economy, said Lisa Kuuttila, president and CEO of the University of New Mexico’s Science and Technology Corp., UNM’s technology transfer office.
UNM originally licensed the technology for IntelliCyt, which sells super-fast cytometers, or cell meters, for medical discovery. The company launched in 2006. It further developed the UNM technology into a marketable product, and then built the firm into an established company with $13.4 million in sales in 2015 and projections of $18 million in 2016.
Support your local Albuquerque Journal & Kevin Robinson-Avila SUBSCRIBE NOW cancel anytime